Se
Seagen (Pfizer)
Bothell WAFounded 19983,200 employees
Private CapbiotechAcquiredOncology
Platform: ADC Platform
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SEA-4335 | SEA-4335 | Phase 3 | 2 | PARP | PompeET | ||
| Semacilimab | SEA-6175 | Phase 3 | 1 | SHP2 | Pancreatic CaGIST |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)